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Paternal exposure to benzo(a)pyrene induces
genome-wide mutations in mouse offspring
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Tomas Fitzgerald3, Matthew E. Hurles3, Francesco Marchetti 2 & Carole L. Yauk2
Understanding the effects of environmental exposures on germline mutation rates has been a
decades-long pursuit in genetics. We used next-generation sequencing and comparative
genomic hybridization arrays to investigate genome-wide mutations in the offspring of male
mice exposed to benzo(a)pyrene (BaP), a common environmental pollutant. We demonstrate
that offspring developing from sperm exposed during the mitotic or post-mitotic phases
of spermatogenesis have signiﬁcantly more de novo single nucleotide variants (1.8-fold;
P < 0.01) than controls. Both phases of spermatogenesis are susceptible to the induction of
heritable mutations, although mutations arising from post-fertilization events are more
common after post-mitotic exposure. In addition, the mutation spectra in sperm and offspring
of BaP-exposed males are consistent. Finally, we report a signiﬁcant increase in transmitted
copy number duplications (P= 0.001) in BaP-exposed sires. Our study demonstrates that
germ cell mutagen exposures induce genome-wide mutations in the offspring that may be
associated with adverse health outcomes.
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There is growing recognition of the importance of heritablemutations across a broad array of human genetic diseases.However, germline mutations are rare (10−8 per nucleo-
tide)1, and studying these mutation events has been difﬁcult
historically because of technological limitations. Consequently,
there are no accepted human germ cell mutagens, although many
rodent germ cell mutagens have been identiﬁed2.
Advances in genomic technologies, speciﬁcally next-generation
sequencing (NGS) and comparative genomic hybridization arrays
(aCGH), have allowed de novo mutation rates, and spectra to be
studied at the genome-wide level3,4. These technologies have been
applied to conﬁrm previous observations that paternal age is a
strong determinant of de novo mutation rate, with older fathers
passing on more mutations to their children than their younger
counterparts5,6. Hence, paternal age is now considered the ﬁrst
conﬁrmed human germ cell mutagen. Similarly, more recent
evidence suggests that maternal age7 and dioxin8 also increase the
mutational burden in humans. These ﬁndings emphasize the need
to identify both the endogenous and exogenous factors that may
be contributing to human germ cell mutagenesis and genetic
diseases.
Many paternal mutations are assumed to occur spontaneously
during DNA replication in self-renewing spermatogonial stem
cells. As a result, the contributions of paternal environmental
exposures to mutation formation are likely underestimated. We
have previously demonstrated that even small (e.g., 10%)
increases in germline mutation rates can have serious public
health implications9. Pedigree studies in mice have demonstrated
that exposures to DNA-damaging agents lead to the transmission
of induced de novo mutations10. New whole-genome approaches
in animal models support the hypothesis that paternal environ-
mental exposures contribute to heritable mutagenesis. For
example, Adewoye et al.11 demonstrated using aCGH and NGS
that paternal radiation exposure induces large deletions and
clustered mutations (multisite mutations) in the genomes of their
offspring. This provided proof of principle that whole-genome
approaches can be used to investigate the role of environmental
exposures in inducing de novo genome-wide mutations through
the germline.
Here, we applied genomic tools to study the consequences of
paternal exposure to benzo(a)pyrene (BaP), a ubiquitous envir-
onmental pollutant, on the mouse germline. BaP is an IARC class
1 carcinogen12 that is metabolically activated by cytochrome
p450s to produce reactive metabolites, such as 7,8-dihydrodiol-
9,10-epoxide (BPDE)13, that form bulky DNA adducts. These
DNA lesions can cause strand breaks, and replication of DNA
unrepaired adducts leads primarily to G to T mutations14. We
previously showed that the same exposure used in this study
induces a fourfold increase in mutation frequency in a transgenic
reporter gene15, and a twofold increase in microsatellite
mutations16,17 in mouse sperm. Here, we directly compare the
spectrum and frequencies of mutations measured in exposed
germ cells from these previous studies to mutations found in
the offspring and demonstrate that paternal exposure to BaP
induce genome-wide mutations in the offspring. The similarity in
the mutation spectra observed in the sperm of exposed males
and their offspring supports the heritability of environmentally
induced germ cell mutations.
Results
Experimental approach. We investigated the effects of paternal
BaP exposure on genome-wide heritable mutation frequencies
and spectra in the unexposed offspring (experimental design
shown in Fig. 1). MutaMouse males received 0 or 100 mg/kg of
BaP dissolved in olive oil via oral gavage for 28 days, and were
mated with C57Bl/6J females to facilitate the assessment of the
parental origin of mutations. Matings occurred 3 and 42 days
after the last daily exposure, and no reduction in litter size was
observed in matings with BaP-exposed males versus control
matings (data not shown).
The two mating points were selected to investigate the
induction of mutations during phases of spermatogenesis that
differ in DNA repair activity. The 3-day time point was chosen to
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Fig. 1 Experimental design. Twenty MutaMouse males received 28 daily doses of 0 or 100mg/kg BaP. The sperm from six controls and six BaP-exposed
males were collected 42 days after exposure and analyzed for the presence of lacZ mutations15 and microsatellite mutations17, and for mutation spectrum
analysis27. Twelve randomly selected control and BaP-exposed males were mated with untreated C57Bl/6 females 3 and 42 days after the end of the
exposure and their offspring analyzed for the presence of single nucleotide variants (SNVs) and copy-number variants (CNVs)
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study offspring developing from sperm exposed to BaP during the
post-mitotic phase of spermatogenesis (spermatocytes and
spermatids), which lacks DNA synthesis and has reduced repair
capabilities4. These processes are required to ﬁx BaP lesions into
mutations; consequently, no mutation induction should occur in
these cells18. Indeed, we showed in a parallel study that the
exposure used herein causes a fourfold increase in mutant
frequency in the lacZ transgene of sperm exposed as spermato-
gonia, but not as spermatids15. However, sperm DNA lesions can
be converted into mutation in the egg following fertilization19,20,
when the oocyte’s DNA repair activity21 is unable to repair all
lesions. Replication of unrepaired BaP lesions in sperm DNA
during the ﬁrst cellular divisions would convert those lesions into
mutations in the developing embryo that would appear as
embryonic mutations with a variant allele fraction (VAF) of ~0.25
(see the Methods section; Supplementary Fig. 1). The latter time
point was chosen to investigate offspring developing from sperm
exposed during the mitotic phase (stem cells and differentiating
spermatogonia) of spermatogenesis, which has active DNA
repair22, when mutations can be ﬁxed in the developing germ
cells and are already present before the sperm fertilizes the egg.
These mutations are expected to appear as de novo mutations
with a VAF of ~0.5. Thus, we hypothesized that BaP exposure
would lead to increases in the number of induced mutations in
the offspring at both mating times, but with a different
proportion of de novo versus embryonic mutations.
Two approaches were used to quantify and characterize
genome-wide mutations occurring before and after fertilization.
The ﬁrst approach involved whole-genome sequencing (WGS) of
family quintets (sire, dam, and three offspring) using spleen DNA
to identify all detectable mutation events. The whole genomes of
two control families 42 days after the last oral gavage, and two
treated families from both mating periods, were sequenced. Thus,
a sample size of six offsprings per treatment group was studied,
except for one control family where sequencing quality metrics
were below thresholds for one offspring sample and the data were
not used. The two BaP-treated sires used for mating in the post-
mitotic group were also used for mating in the mitotic group.
Putative mutations were cross-validated using Illumina® targeted
re-sequencing. For the second approach, CGH arrays were used
to identify de novo copy-number variations (CNVs), again by
comparing offspring to parental DNA. In total, liver DNA from
171, 83, and 98 offsprings were analyzed for de novo CNVs in
control, post-mitotic, and mitotic groups, respectively. All CNVs
were validated using real-time PCR and by mate-pair NGS.
Broadly, the WGS and CNV results of this study were used to
(1) determine whether paternal BaP exposure increases the
number of inherited mutations; (2) explore whether pre-
mutational lesions in sperm are converted into mutations in the
offspring after fertilization; and (3) contrast mutagenic effects in
germ cells with those occurring in offspring.
De novo single-nucleotide variants and indels. We used WGS of
two families from the control, and post-mitotic and mitotic
exposure groups to investigate the induction of single-nucleotide
variants (SNVs) and indels following paternal exposure to BaP.
WGS followed by targeted re-sequencing identiﬁed 275 true
mutations (average 18 per BaP animal; 11 per control; Supple-
mentary Data 1). In total, 190 validated variants were de novo
(average 13 per BaP animal; seven per control; Supplementary
Data 1), 73 were early embryonic (average ﬁve per BaP animal,
three per control; Supplementary Data 2), six were germline
mosaics in the parents (three mutations shared by two siblings),
and six were somatic mosaics in the parents. The spontaneous de
novo mutation frequency in this study was 3.1 ± 0.7 × 10−9,
which is lower than other estimates using different
technologies11,23, but is within range. The proportion of mosaic/
embryonic mutations among SNVs/indels was ~25%, which is
highly consistent with previous measurements in mice with a
larger sample size (non-peer reviewed study)23. Four de novo and
three embryonic mutations were identiﬁed as nonsilent mutations
within genes by Ensembl Variant Effect Predictor24 (four treated;
three control; Supplementary Data 3). Haplotype phasing of the
mutations, where possible, indicated that most mutations were
paternal in origin (22 paternal, ﬁve maternal; Supplementary
Data 4).
Overall, the number of de novo mutations passed onto
offspring was higher in the BaP group (65 mutations in six
offspring from the post-mitotic exposure group, 88 mutations in
six offspring from the mitotic exposure group) compared with
olive oil-treated controls (37 mutations in ﬁve animals). The total
number of de novo mutations in the BaP group was 1.7-fold
higher than controls (adjusted P= 0.036 using generalized
estimating equations (GEE) for individual offspring effects).
Furthermore, BaP exposure elevated the total number of
mutations (i.e., both embryonic and de novo) per offspring by
~1.8-fold (adjusted P= 0.04; GEE; Table 1; Fig. 2; 103+ 110 BaP
mutations in 12 animals vs. 50 control mutations in ﬁve animals).
When analyzed based on the window of spermatogenic exposure,
we observed that de novo mutations were signiﬁcantly increased
only after exposure of the mitotic phase (adjusted P= 0.03, GEE),
while embryonic mutations were signiﬁcantly increased only after
post-mitotic exposure (adjusted P= 0.038, GEE). Taken together,
these results support the expected mechanism of mutation
induction and provide strong evidence that BaP-induced sperm
mutations are heritable and genome-wide.
A large portion (10/12) of offspring in the BaP-exposed group
had a higher number of mutations than the mean number
of mutations in controls. Moreover, there was a large degree of
variation among the offspring of BaP-treated males, with seven
of the mice having numbers of mutations outside the range of
control mutations and ﬁve mice being within the control range.
This observed variability in mutations occurred within litters,
indicating that this was not due to differences in exposure levels
among sires but to different amount of damage among the
fertilizing sperm. We estimate, based on previous measurements of
BaP adducts25, that the dose and frequency of the exposure would
lead to ~1000 bulky DNA adducts per genome. The detection of
the de novo SNVs indicates that some of these adducts elude DNA
repair, while the observation that only some animals have elevated
mutation levels suggests that BaP is not evenly distributed across
the germ cell population during exposure. Alternatively, different
cells may respond differently to exposures, possibly through
adaptive upregulation of different DNA repair genes26. Hence,
only a certain percent of animals would have BaP-associated SNVs
and indels or show an overall increase in genome-wide
mutation count.
The mutation spectra of the seven offspring with the highest
numbers of mutations (Fig. 2) revealed that these extra mutations
were consistent with the mutation spectrum of BaP (i.e., increased
frequency of G:C→ T:A, G:C→ C:G) observed in the sperm and
bone marrow of exposed males14,27. Furthermore, there was also
an increase in the number of G:C → A:T mutations (Fig. 2).
Overall, the mutation spectrum in the affected animals in the
exposed group was signiﬁcantly different than that observed in
unaffected animals and controls (Fisher’s exact P= 0.0009).
Next, we explored how our BaP-induced mutation spectrum
aligns with mutation signatures found in human cancers from the
“Catalogue Of Somatic Mutations In Cancer” (COSMIC)
database28. About 23% of SNVs (total de novo and embryonic
SNVs across animals; Supplementary Data 5) in the seven
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offspring with elevated numbers of mutations were aligned with
COSMIC Signature 4. This signature is derived from mutations in
human lung cancers of tobacco smokers29, and is the major
signature found after exposure to BaP30. There was no association
between Signature 4 and mutations in the mice with lower
numbers of mutations, supporting that the extra mutations in the
affected animals resulted from BaP exposure. Overall, these
ﬁndings provide strong support that the additional mutation
burden is due to the presence of the bulky BPDE adducts at
guanine nucleotides, conﬁrming the effects of BaP on both de
novo and embryonic mutation induction.
Four of the seven animals with elevated mutation levels
developed from sperm exposed to BaP during the post-mitotic
phases of spermatogenesis (Fig. 2). This provides further support
to the hypothesis that DNA damage occurring in later phases of
spermatogenesis can lead to mutation formation in the develop-
ing embryo. Interestingly, the animal with the most embryonic
mutations (32CM1) had 12 BaP-type mutations in total with
evidence of some clustered mutations. Speciﬁcally, this mouse
had three G:C→ T:A mutations (VAF: 0.18–0.21) within a 45 -kb
window on chromosome 12 and two G:C → T:A mutations
(VAF: 0.31–0.35) within a 438 kb window on chromosome 17.
Considering that the average spacing of mutations across all
animals was 8.9 Mb, it is unlikely that these mutations occurred
close together by chance alone31. Furthermore, the mutational
ﬁngerprint of these events indicates that they were likely a result
of BaP adducts, and the similarities in VAFs indicate that the
mutations formed concurrently as that genomic region was
replicated during early embryonic development. Previous obser-
vations suggest that the earliest cell divisions during embryogen-
esis have the highest spontaneous mutation rates compared with
any other germline stage32 and conﬁrmed in non-peer reviewed
work33. The evidence presented here also suggests that these early
stages represent a sensitive window by which DNA damage leads
to genetic mosaicism in the developing organism.
The overall increase in mutation count in the BaP-exposed
offspring was unexpectedly lower than the increase in mutation
frequency observed in sperm following the exact same exposure
(approximately twofold vs. fourfold, respectively)15. There are a
few possibilities that could explain this: (1) the small number of
meioses analyzed in the pedigree study versus the sperm work
(four meioses per group for the pedigree study, >1,00,000 per
group in the sperm study) may lead to lower accuracy in the
pedigree approach; (2) negative selection against germ cells and
embryos with the highest amounts of DNA damage decreased the
number of detectable mutations in BaP offspring; (3) mutation
induction in the transgene analyzed in sperm does not provide an
accurate representation of the mutation induction in the rest of
the genome, which could occur if there are sequence or region
biases that make this transgene a mutational hotspot; and (4) a
disproportionate amount of BaP mutations were missed com-
pared with the control using the WGS approach. The latter would
most likely be due to the high probability of BPDE adducts
forming in regions rich in CG nucleotides that are difﬁcult to
sequence.
A combination of technical issues with sequencing and
stringent bioinformatics ﬁltering cannot be ruled out to explain
the lower than expected number of mutations retrieved. For
example, indels accounted for 33% of the BaP mutations detected
in sperm27, and only a few indels were detected in the genomes of
the offspring. Based on the functional mutations observed in the
lacZ gene in sperm of BaP-exposed mice27, we estimated the total
number of expected mutations in the genomes of offspring from
the control and BaP-treated sires. In total, there were ~60
mutations detected in 11.5 Gb and 300 mutations in 10.9 Gb for
the control and BaP sperm, respectively. Assuming a random
distribution of mutations, there should be ~32 and 170 mutations
per diploid genome in the control and BaP mice, respectively. By
this logic, 31% of possible control mutations were detected by
WGS, but only 10% were detected in the BaP group. Thus,
although we have shown that BaP induces genome-wide
mutations, the discrepancy between the expected and observed
number of mutations suggests that the full extent of the damage
induced by BaP remains uncertain.
Table 1 De novo mutations in the offspring of the control and BaP-treated animals
Mutation type Exposure group Sample
sizea
Number of
mutations
Mutations per offspring
(95% CI)
Ratio to
controlb
P-valued Holm–Sidak
adjustmentd
De novo SNVs/indels Control 5 37 7.4000 (5.4845–10.7368) − −
Post-mitotic 6 65 10.8333 (8.8010–14.5347) 1.46 0.074 0.074
Mitotic 6 88 14.6667 (12.3822–19.0208) 1.98 0.010 0.030
All BaP 12 153 12.7500 (11.3787–15.7242) 1.72 0.018 0.036
Embryonic SNVs/indels Control 5 13 2.6000 (1.4573–4.6801) − −
Post-mitotic 6 38 6.3333 (4.7177–9.1505) 2.44 0.013 0.038
Mitotic 6 22 3.6667 (2.4188–5.8436) 1.41 0.220 0.220
All BaP 12 60 5.0000 (4.0163–6.7747) 1.92 0.050 0.097
Total SNVs/indels Control 5 50 10.0000 (7.8128–13.8776) − −
Post-mitotic 6 103 17.1667 (14.7495–21.9153) 1.72 0.001 0.003
Mitotic 6 110 18.3333 (15.8608–23.2596) 1.82 0.005 0.005
All BaP 12 213 17.7500 (16.2591–21.3690) 1.78 0.002 0.004
Large deletions Control 171 3 0.0175 (0.0036–0.0527) − −
Post-mitotic 83 1 0.0120 (0.0001–0.0716) 0.69 0.604 0.604
Mitotic 98 0 0.0000 (0.0000–0.0323) 0.00 0.255 0.587
All BaP 181 1 0.0055 (0.0001–0.0338) 0.31 0.290 0.496
Duplications/insertions Control 171 0 0.0000 (0.0000–0.0188) − −
Post-mitotic 83 3 0.0361 (0.0080–0.1053) 5.60 0.034 0.099
Mitotic 98 2 0.0204 (0.0011–0.0759) 4.04 0.132 0.132
All BaP 181 5c 0.0276 (0.0101–0.0648) 3.45 0.035 0.069
aSample size refers to the number of offspring analyzed in each group
bIn the cases where the ratio was undeﬁned (control rate= 0) the upper limits of the 95% CI were used to estimate the ratio
cTwo of the CNVs occurred as a single event in one of the mice in the post-mitotic group. Thus, we report the number of mutations in this group as 3 and not 4, and the total count is reported
conservatively as 5 instead of 6
dStatistically signiﬁcant P-values are indicated in bold
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There were limitations that prevented the estimation of
mutation rate for each sire. First, the work was somewhat
confounded as multiple offspring per male were sampled. Second,
there was a large degree of variability among siblings with no
apparent litter effects. However, the variation in the number of
BaP-induced mutations in each offspring appears to be a
biological and not a technical result. Future work that precisely
measures mutation frequency in individual sperm using techni-
ques such as error-corrected sequencing34 could shed light on this
type of variability and its inﬂuence on chemically induced de
novo mutation rates.
de novo CNVs. We applied stringent ﬁlters to identify CNVs
from the aCGH analysis of pedigrees and then validate each
candidate with real-time PCR and breakpoint sequencing (Fig. 3;
see the Methods section). This resulted in a ﬁnal set of ten con-
ﬁrmed de novo and two germline mosaic CNVs (Supplementary
Data 6). The spontaneous de novo deletion CNV frequency
observed in our control mice (1.8%; 3/171) was comparable with
previous estimates (1.5%; 2/136) using combined data from
two published mouse studies11,35. The frequency of deletion
CNVs in the treated group was 0.5–1% (1/83, 0/98 for the two
time points, respectively; 1/181 total); hence, there was no evi-
dence for induction of deletions (Table 1). In contrast, there
was an increase in duplication CNVs in the treated group (4/83,
2/98 for the two time points, respectively; 6/181 total) relative
to the control animals (0/171; Fig. 4; Table 1; Supplementary
Data 6). Two of the duplication CNVs occurred in the same
animal, thus, the total number of CNVs was conservatively
counted as ﬁve. Using this number, the increase in duplications in
the BaP group was at borderline of signiﬁcance (Fisher’s exact
test, adjusted P= 0.08). However, the ﬁve BaP-induced duplica-
tion events occurred in ﬁve different litters from four sires (males
32, 33, 37, and 39). Male 32 had an offspring with a duplication
CNV at both time points, one involving chromosome 3 and
the other chromosome 16; while male 33 had a male offspring
with a duplication involving chromosome 5 and a female off-
spring with a deletion involving chromosome 3 within the same
litter (Supplementary Data 6). Using sires as the biological unit,
and considering the number of offspring analyzed for each sire
(Supplementary Data 7), yields a statistically signiﬁcant increase
in the frequency of duplication CNVs (0.0278 vs. 0; Fisher’s
exact test, adjusted P < 0.001) demonstrating that this result is
not due to clustering within a litter or within a BaP-exposed
male. Indeed, the spontaneous frequency of duplications appears
to be rare compared with deletions, as only a single duplication
was detected from 93 control animals from Adewoye et al.11,
43 control animals from Arlt et al.35, and 171 animals in this
study. Thus, although we have recovered few duplications
overall, this increase in the exposed mice is unlikely to be due to
chance alone.
Duplication events have potential phenotypic consequences as
they can disrupt gene dosage and homeostasis. Furthermore, a
duplicated sequence can be inserted within a gene and disrupt
that gene’s function. Therefore, we used sequencing to character-
ize the breakpoints of the CNVs to elucidate both the nature
of these BaP-induced duplications (tandem vs. inserted) and
the mechanism for their formation. We found that three of
the six duplication CNVs were insertions at other locations in
the genome (different chromosomes). Two of these insertion
CNVs were present in the same animal (Supplementary Fig. 2A),
but on separate chromosomes (4 and 10; Table 1). Sequencing
revealed that the two CNVs were joined together as an insertion
into a long interspersed nuclear element (LINE: L1Md_T). The
exact location of this insertion could not be determined due
to the repetitive structure and abundancy of this LINE. The
other insertion (Supplementary Fig. 2B) involved a region from
chromosome 16 being copied into a satellite sequence
(GSAT_MM) on another chromosome (most likely chromosome
2 based on the 97% sequence identity at the breakpoint).
Remarkably, both breakpoints had nucleotide similarity to the
satellite sequence indicating that normal replication of the
satellite resumed after insertion of the chromosome 16 donor
sequence. The other three duplication CNVs occurred in tandem
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Fig. 2 Mutation counts and spectra in the control and BaP offspring as
measured by WGS. a Each circle, triangle, and square represent one
offspring from the control (n= 5 animals), post-mitotic (n= 6 animals),
and mitotic (n= 6 animals) exposure groups, respectively. The dashed lines
connect the embryonic and de novo mutations for the respective animals.
For analytical purposes, we called the offspring above the dark blue lines
(above the means of the BaP-exposed group) as “affected” by BaP, and
those below “unaffected.” b Separating the BaP offspring into two groups
(affected, and unaffected) shows that the additional mutations in the
affected mice match the mutation ﬁngerprint of BaP indicated with asterisks
(G:C → T:A, G:C → C:G; Supplementary Data 1; Supplementary Data 2;
generalized estimating equations P≤ 0.0027). Furthermore, there is an
increase in G:C → A:T mutations (shown in asterisks, generalized
estimating equations P= 0.0010). In our previous analyses, we observed
a decrease in proportion of this mutation type, but the absolute mutation
frequency is increased14,27. Overall, the mutations induced by BaP occur
at guanine nucleotides as expected. Source data can be found in
Supplementary Data 8
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(Supplementary Fig. 2C, D). One of the tandem duplications was
a complex event involving a 28 -bp insertion from a region 16 kb
upstream from the nearest breakpoint (Supplementary Fig. 2C).
The orientation of the discordant mate pairs also signiﬁed that
this event was associated with an inversion, further highlighting
the complexity of this mutation and the region where it occurred.
Given that some CNV breaks in our study were within satellite
DNA, and that only large CNVs can be detected in such low-
complexity sites as a result of the aCGH design, it is probable that
CNVs of moderate size in repetitive regions of the genome were
undetected.
All of the de novo CNVs with detectable breakpoints appear to
have been mediated by overlaps consisting of short microhomol-
ogies of 1–6 bp between sequence breakpoints (Supplementary
Data 6). These events are similar to the CNVs detected in
irradiated human ﬁbroblasts36 and in the germline of mice
exposed to hydroxyurea35 where 1–8 -bp homologies were
observed at most breakpoint junctions. The CNVs with
microhomology preclude involvement of homologous recombi-
nation repair (HRR) because the sequence homology required for
HRR is >200 bp37. The model that best explains these mutation
events is microhomology-mediated break-induced replication
(MMBIR)38,39, which is an alternative DNA repair pathway
invoked to repair double-strand DNA breaks.
The results of this study and previous observations40 suggest
that deletions occur more commonly in the mouse germline, and
that duplication CNVs form infrequently in the absence of
replication fork collapse near DNA damage. Indeed, it has been
postulated that MMBIR favors the formation of gains over losses,
and that an enrichment of duplications represents a mutational
signature that may require environmental stress41. In this
experiment, BPDE was likely the main environmental stress
leading to replication fork collapse and subsequent MMBIR. In
addition, BaP metabolism creates reactive oxygen species42
capable of inducing replication fork collapse via base excision
repair mechanisms. An excess of collapsed replication forks in the
presence of BaP damage may lead to Rad51 depletion, inhibiting
strand invasion into the homologous sequence required for
HHR38, leading to pre-fertilization CNVs in spermatogonia.
Likewise, mature sperm lack homologous chromosomes to guide
repair, leading to post-fertilization CNVs in the developing
embryo. In lieu of a homologous template, the collapsed fork
invades an active replication fork within physical proximity using
the microhomology as a primer. This hypothesis is supported by
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previous observations using a bacterial model investigating BPDE
adducts43. Speciﬁcally, DNA segments containing BPDE adducts
were more likely to be deleted or replaced with an alternative
sequence (>42 bp) than segments without adducts (no alterations
observed). Similar to the CNVs detected here, the breakpoints of
the alterations showed microhomology (most often 2 bp) and the
alterations occurred independent of RecA (Rad51 homolog).
Taken together, these ﬁndings suggest that BPDE adducts lead to
fork collapse and instability, favouring MMBIR, which copies
DNA from another source at the site of fork collapse.
There are limitations to our de novo CNV analysis. First, the
ability to detect CNVs that were present as mosaics was limited
(see Supplementary Discussion, Supplementary Figs 5, 6). Second,
assigning the parental origin of each CNV was challenging.
Parental origin could only be assigned for four of the nine de
novo CNVs. All four were paternal in origin. Thus, total (rather
than paternal exclusive) CNV frequencies were compared
between the control and BaP animals due to the inability to
determine the parental origin for all CNVs. Because CNV
occurrence per sire is rare, it is difﬁcult to precisely estimate the
rate of CNV formation to compare rates across fathers. In order
to determine CNV frequencies for individual sires, single-sperm
analyses should be applied. Further work is required to better
understand the relationship between DNA adducts and CNV
duplication/insertion frequencies.
Conclusions
We found that de novo mutations are elevated in the descendants
of BaP-exposed males, consistent with increases in sperm muta-
tion frequencies. De novo mutations can occur during exposure
of stem cells and spermatogonia, and are transmitted to offspring.
Our approach also enabled the detection of mutations originating
as DNA damage in mature sperm that are undetected by existing
sperm assays27. These results conﬁrm that mature sperm repre-
sent a sensitive window of spermatogenesis by which exposure to
DNA-damaging agents can lead to mutations in the embryo. An
important ﬁnding from this study was that many of the heritable
mutations are mosaics. Thus, caution is required in interpreting
exposure-related mutations to ensure that the damage caused by
the exposure is not underestimated through application of
ﬁltering approaches that eliminate such mutation events. Overall,
BaP exposure caused SNVs as well as non-recurrent duplication
CNVs, the latter representing an endpoint that is not currently
considered in genetic toxicology testing. This research demon-
strates the promise offered by applying whole-genome approa-
ches to the study of heritable mutagenesis. Our results have
potential human health implication because BaP is a ubiquitous
environmental pollutant and continuous exposure to low doses is
unavoidable. Future work should explore the dose–response
relationship to enable a more informed understanding of risk of
various environmental, lifestyle, and dietary exposure to BaP. Our
results also emphasize that men need to be aware long before
family planning as well as in the weeks leading in to conception
that their lifestyle is important for the future health of their
children.
Methods
Benzo(a)pyrene exposure and mouse breeding. All animal procedures were
conducted according to conditions approved by the Health Canada Ottawa Animal
Care Committee. The BaP exposure was conducted in parallel with the exposure
done in previous studies15,16,27. Twenty MutaMouse males (BALB/C × DBA/2)44,
~15 weeks of age, were exposed daily to BaP (Sigma-Aldrich, Oakville, Ontario,
Canada) dissolved in olive oil (Sigma-Aldrich; highly reﬁned, low acidity) via oral
gavage (~150 µL) for 28 days (100 mg/kg body weight/day). This dose was selected
based on the results of a pilot study that indicated that a higher dose would have
resulted in signiﬁcant toxicity and morbidity to the animals15. Twenty concurrent
males received olive oil and served as negative controls. Three days after the last
treatment, 12 randomly chosen control and BaP-treated males were mated with up
to four C57Bl/6J females each over a 2-week period to produce offspring derived
from germ cells exposed during the post-mitotic phase of spermatogenesis. This
exposure window covered most of meiosis and the entirety of spermiogenesis
(post-mitosis). Breeding was repeated 42 days after the last treatment with four
new C57Bl/6J females per male to produce offspring from germ cells exposed
during the mitotic phase of spermatogenesis. One of the controls and three of
the BaP-treated males did not produce litters at both time points, while another
BaP-treated male needed to be euthanized before the completion of the experi-
ments. Thus, 11 controls and eight BaP-treated males produced litters that were
used in this study.
The offspring produced from each mating were weaned at ~3 weeks. Each
offspring was identiﬁed by a code that included a number for the father, a letter
for the mother followed by either an M for male or F for female, and a second
number indicating the sequence of weaning. For example, 3HF1 identiﬁes the ﬁrst
female from the litter produced by mating male 3 with female H (note that the
female letter code was the same for each male, thus, each male was mated with
females identiﬁed with letters A to H). Three weeks after birth, litters and dams
were anaesthetized with isoﬂourane and euthanized via cervical dislocation. Sires
were euthanized after tissue samples from the offspring were collected. From
each animal in the quintet, the liver, spleen, and brain were collected and stored
at −80 °C. The six additional controls and BaP-treated males were euthanized at
42 days, and sperm analyzed for the presence of lacZ mutations15, microsatellite
mutations17, and determining the mutation spectrum induced by BaP27.
Whole-genome sequencing. Two of the families from each group used for array
analysis were chosen at random for WGS. Each family consisted of a sire, dam, and
three offspring. DNA was extracted from the spleen using the DNeasy Blood &
Tissue Kit (Qiagen), and NGS libraries were built using NEBNext® Fast DNA
Library Prep Set for Ion Torrent™ (New England Biolabs, Whitby, Ontario,
Canada) according to the manufacturer’s instructions. NGS was performed in-
house using the Ion Chef™ and Ion Proton™ instruments (Thermo Fisher Scientiﬁc,
Burlington, Ontario, Canada). Each genome was sequenced to an average auto-
somal coverage of ~31×.
De novo mutation calling and ﬁltering. Sequence data were aligned to the
GRCm38/mm10 reference genome using the Torrent Mapper, and the Torrent
Variant Caller was used to call variants (Torrent Suite version 5.0.2). Genomic
variant call ﬁles (gVCFs) were merged, and Mendelian violations (MVs) between
offspring and parents were called and ﬁltered to eliminate false-positive calls.
Speciﬁcally, the loci ±10 bp of each putative MV were examined for allelic depth
using samtools (v. 1.3). MVs were kept if they met the following criteria: the VAF
for the variant in the parents was <5%, VAF in the offspring was >25%, the fraction
of reads with mapping quality of zero did not exceed 0.1, read depths for all
animals was at least seven, and the Fisher’s exact test for strand bias had a P-value
> 0.05. Variants occurring within repeat sequences and other related elements were
removed from further analysis. A total of 2728 variant calls passed ﬁltering
(average of 160 per animal) and were selected for validation (Supplementary
Data 1).
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We considered variant allele fractions (VAFs) for each mutation to determine
whether it originated as a de novo (already present in sperm) or embryonic
mutation arising in early embryonic division. The timing and kinetics of the
mutation occurrence during spermatogenesis will dictate if mutation ﬁxation will
occur before or after fertilization. For example, if a BaP adduct is formed and
ﬁxation leads to a mutation during mitosis in the parental gamete, the mutation
will have a VAF of 0.5 in the developing embryo and will be called as de novo. If an
adduct is formed after mitosis, when there is no DNA replication and repair is
declining, the resulting mutation will most likely arise in the ﬁrst embryonic
division and will appear as embryonic with a VAF of 0.25. However, segregation
and distribution of the mosaic mutation could lead to varying VAFs in the animal
and its adult tissues. Previous studies have shown that three cells from the 64-cell
stage go on to form the entire animal45. In these three cells, there would be six
haploid genomes total (three paternal, three maternal). Therefore, the VAFs for
embryonic events could potentially be 0.17 (1/6), 0.33 (2/6), or 0.5 (3/6) when there
are one, two, or three mutant cells that form the animal, respectively
(Supplementary Fig. 1).
Cross-platform targeted re-sequencing validation. Mutations were validated by
Agilent Sure Select Target Enrichment as described (non-peer reviewed study)23.
Bait design was successful for 2261 of the 2728 putative variants (Supplementary
Data 1). After enrichment, all variants were multiplexed and sequenced to ~ > 300x
coverage using Illumina sequencing. Duplicates were removed and in-house scripts
were used to quantify read counts at each candidate site to determine if the variant
was a true de novo, inherited, or a false positive based on parental and child VAFs
(Supplementary Fig. 3). The Integrative Genomics Viewer46 was used to manually
inspect all conﬁrmed mutations. Further ﬁltering was applied to eliminate mosaic
mutations (mutations called in siblings) and mutations that occurred during
embryogenesis (VAF in offspring <39%; Supplementary Fig. 4).
Mutation frequency estimation. Bedtools47 was used to estimate the percent of
autosomal nucleotides in the diploid mouse genome (4.7 GB)48 covered by NGS
reads (≥10x coverage). Approximately 93% of the genome (4.4 GB) was covered by
NGS reads in each animal. Repetitive DNA sequence regions, according to
Repeatmasker49, were removed (45% of diploid genome) leaving 2.4 GB of the
autosomal diploid genome where mutations could be detected. True de novo
mutations with a VAF > 39% in the autosomes were divided by the number of
autosomal nucleotides to estimate mutation frequency.
Comparative genomic hybridization and CNV detection. Agilent SurePrint G3
Mouse CGH arrays with 1 M probes (G4838A; Agilent Technologies, Mississauga,
Ontario, Canada) were used to detect de novo CNVs in the litters produced
from mating MutaMouse sires with C57Bl/6J dams. The manufacturer’s
instructions were followed for each aCGH experiment (Agilent Oligonucleotide
Array-Based CGH for Genomic DNA Analysis; version 7.3). Speciﬁcally, high-
molecular weight DNA was extracted from the liver of each animal using the
DNeasy Blood & Tissue Kit (Qiagen, Montreal, Quebec, Canada). Two of the BaP-
treated males exhibited high degrees of somatic mosaicism in their liver,
apparent by the presence of several false-positive CNV calls in the offspring, and
therefore brain DNA was used instead. One microgram of offspring DNA was
labeled with Cy5 dye (5190–3400 SureTag DNA Labeling Kit). Five hundred
nanograms of DNA from each respective parent were mixed together and labeled
with Cy3 dye. As positive controls, and to identify existing strain differences,
two additional arrays were used to compare MutaMouse with C57BL/6J DNA.
DNA labeled with Cy3 and Cy5 were mixed together for hybridization onto the
CGH array.
The hybridized slides were scanned using an Agilent C scanner, and Feature
Extraction v10.5 was used to extract the data. Following Feature Extraction, signal
intensities (Cy3 and Cy5) were background subtracted and then normalized
(Lowess normalization using Rank invariant probes). Nonuniform features (outlier
probes with signals inﬂuenced by array position) were removed from analysis. The
algorithms previously used by Adewoye et al.11 were applied to detect autosomal
CNVs as genomic segments with parent vs. offspring ﬂuorescent signal log2 ratios
above or below threshold values as described previously50. Speciﬁcally, de novo
CNV duplications/deletions were called if they had an absolute |log2 ratio| > 0.4
(1.32-fold higher signal) and the CNV segment was a minimum of ﬁve consecutive
altered probes. Probes had an average spacing of ~3,000 bp; therefore, this
approach detected CNVs that were at least ~15,000 bp in size. Only unique CNVs
(i.e., observed once only) were considered to eliminate multi-allelic CNVs that
existed in the parents and were unlikely to be de novo mutations. Lastly, CNVs
were identiﬁed as germline mosaic when they were present in a portion of the
siblings from the same sire, but not in any offspring from a different sire.
CNV Validation. Real-time PCR using TaqMan® Copy Number Assays that
targeted the CNV regions were analyzed using a CFX96™ Real-Time System (Bio-
Rad, Saint-Laurent, Quebec, Canada) to validate putative de novo CNVs. The
mouse transferrin receptor gene (Tfrc) was used as a reference and analyzed
simultaneously with the CNV targeting assays. Family quartets (sire, dam, offspring
with CNV, offspring without CNV) were analyzed together, and each tissue was
analyzed with at least four technical replicates. The same DNA used in the arrays
from the liver (endoderm) was used for validation. DNA from the brain (ectoderm)
or spleen (mesoderm) was also analyzed for the presence of the CNV in the
offspring to conﬁrm that the CNV was germline in origin and not a result of
somatic mosaicism. CNVs that adhered to Mendelian inheritance patterns or had a
copy number change of <0.5 copies were considered as false positives.
Out of the initial call-set of 30 de novo CNVs (28 unique, two mosaic) that
passed the threshold criteria, 12 were eliminated (six false positives, six inherited
from parent). In four of the six false positives, the relative PCR ampliﬁcation of
mutated offspring liver DNA compared with parental DNA was concordant with
array data; however, the absolute copy number change was less than <0.5 copies.
Thus, these CNVs were more likely to be somatic mosaics that arose during early
embryogenesis as opposed to those in the germ cells51. Of the 18 remaining CNVs,
one failed to amplify after testing multiple assays and was likely a somatic mosaic
based on the array results, 17 CNVs were considered de novo (15 CNVs) or
germline mosaic events (two CNVs). In all cases where SNP information was
available, the CNV was determined to have arisen from the paternal genome (seven
of 17 CNVs). However, there were two deletions (log2 ratio of ≥−0.75), where
neither parental allele dropped out, indicating that the CNVs were somatic events
occurring after fertilization. Therefore, in order for a deletion to be called as a true
de novo mutation the log2 ratio needed to be <−0.75.
Identifying CNV breakpoint and parental origin. Mate-pair libraries were built
for each animal carrying a CNV (Supplementary Data 6) using the Nextera mate
pair library prep kit (Illumina®, Vancouver, British Columbia, Canada). Each
library was sequenced using a NextSeq 500 (Illumina®) sequencer and ~20% of
a high-output ﬂow cell. Following alignment to the mm10 genome using bwa
(version 0.7.12), the regions identiﬁed by aCGH were visually inspected using the
Integrative Genomics Viewer46 to pinpoint the CNV breakpoint sequence and
elucidate the mechanism for formation. The sequence data were also compared
against the MutaMouse and C57BL/6J haplotype information to characterize the
parental origin of each CNV. Loss of the allele in deletions or higher proportion of
the allele in duplications would indicate that the CNV originated in a germ cell
of the parent carrying that allele.
Statistical analyses. Assuming a Poisson distribution for the error, GEEs were
used to analyze SNV/indel data. One-tailed Fisher’s exact tests were used to
compare CNV events between the control and BaP animals. The Poisson dis-
tribution was used for SNV data, and the modiﬁed Wald-method was used to
measure the 95% conﬁdence interval for CNV data. The Holm–Sidak adjustment
was used to control for multiple comparisons. Cosmic Signature analysis was
undertaken using SomaticSignatures52 and deconstructSigs packages53 in R54.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The raw whole-genome sequences and the array data generated for this study are
available in the Sequence Read Archive under BioProject No. PRJNA508974. All other
data are available from the corresponding authors on reasonable request.
Code availability
Custom scripts can be accessed in the GitHub repository: https://github.com/mattjmeier/
HC/tree/master/BaP_pedigree. These were used to identify Mendelian violations between
offspring and parents from genomic variant call ﬁles generated by the Torrent Variant
Caller.
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